AR218711A1 - Procedimiento para producir preparaciones farmaceuticas solidas que contienen gefarnate - Google Patents

Procedimiento para producir preparaciones farmaceuticas solidas que contienen gefarnate

Info

Publication number
AR218711A1
AR218711A1 AR275761D AR27576179D AR218711A1 AR 218711 A1 AR218711 A1 AR 218711A1 AR 275761 D AR275761 D AR 275761D AR 27576179 D AR27576179 D AR 27576179D AR 218711 A1 AR218711 A1 AR 218711A1
Authority
AR
Argentina
Prior art keywords
procedure
pharmaceutical preparations
solid pharmaceutical
preparations containing
producing solid
Prior art date
Application number
AR275761D
Other languages
English (en)
Spanish (es)
Original Assignee
Sumitomo Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co filed Critical Sumitomo Chemical Co
Application granted granted Critical
Publication of AR218711A1 publication Critical patent/AR218711A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AR275761D 1978-03-14 1979-03-09 Procedimiento para producir preparaciones farmaceuticas solidas que contienen gefarnate AR218711A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP53029746A JPS6026093B2 (ja) 1978-03-14 1978-03-14 ゲフアルナート含有固型製剤の製造方法

Publications (1)

Publication Number Publication Date
AR218711A1 true AR218711A1 (es) 1980-06-30

Family

ID=12284653

Family Applications (1)

Application Number Title Priority Date Filing Date
AR275761D AR218711A1 (es) 1978-03-14 1979-03-09 Procedimiento para producir preparaciones farmaceuticas solidas que contienen gefarnate

Country Status (17)

Country Link
JP (1) JPS6026093B2 (cs)
AR (1) AR218711A1 (cs)
BE (1) BE874795A (cs)
CH (1) CH637827A5 (cs)
CS (1) CS207784B2 (cs)
ES (1) ES478539A0 (cs)
FR (1) FR2419729B1 (cs)
GB (1) GB2016271B (cs)
HK (1) HK49283A (cs)
IE (1) IE48269B1 (cs)
IT (1) IT1162282B (cs)
MT (1) MTP843B (cs)
MX (1) MX5996E (cs)
NL (1) NL7901917A (cs)
PH (1) PH16903A (cs)
PT (1) PT69341A (cs)
ZA (1) ZA791103B (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3320583A1 (de) * 1983-06-08 1984-12-13 Dr. Karl Thomae Gmbh, 7950 Biberach Neue galenische zubereitungsformen von oralen antidiabetika und verfahren zu ihrer herstellung
EP0391851B1 (de) * 1989-04-07 1994-06-22 Ciba-Geigy Ag Pestizide Wirkstoffkonzentrate und ihre Herstellung
TW202539626A (zh) * 2023-12-01 2025-10-16 日商Ea製藥股份有限公司 醫藥組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3432593A (en) * 1963-09-18 1969-03-11 Key Pharm Inc Delayed and sustained release type pharmaceutical preparation
JPS5635169B2 (cs) * 1974-02-14 1981-08-15
SE421042B (sv) * 1976-06-29 1981-11-23 Kockums Chem Sett att minska den for en viss biologisk effekt erforderliga mengden biologiskt aktiv substans
JPS53148519A (en) * 1977-05-31 1978-12-25 Sumitomo Chem Co Ltd Preparation of solid medicine containing gefarnate

Also Published As

Publication number Publication date
MX5996E (es) 1984-09-18
HK49283A (en) 1983-11-11
IE790725L (en) 1979-09-14
FR2419729A1 (fr) 1979-10-12
ES8200632A1 (es) 1981-11-01
CS207784B2 (en) 1981-08-31
BE874795A (fr) 1979-07-02
GB2016271B (en) 1982-09-02
JPS6026093B2 (ja) 1985-06-21
IT7948332A0 (it) 1979-03-13
NL7901917A (nl) 1979-09-18
FR2419729B1 (fr) 1988-07-08
PH16903A (en) 1984-04-10
CH637827A5 (fr) 1983-08-31
MTP843B (en) 1980-02-11
ES478539A0 (es) 1981-11-01
GB2016271A (en) 1979-09-26
ZA791103B (en) 1980-03-26
IE48269B1 (en) 1984-11-28
PT69341A (fr) 1979-04-01
JPS54122718A (en) 1979-09-22
IT1162282B (it) 1987-03-25

Similar Documents

Publication Publication Date Title
ES481909A0 (es) Procedimiento para la preparacion de nuevas aril-3 eter-5 o-xazolidinonas-2
MX5631E (es) Procedimiento para la preparacion de acil-anilinas
MX7623E (es) Procedimiento para la preparacion de 4-amino-5-alquil-sulfonil-orto-anisamidas
ES490214A0 (es) Un procedimiento para la preparacion de derivados de feneta-nolamina
ES482499A0 (es) Procedimiento para la preparacion de 2-cloro-6-nitroanilinas
ES494634A0 (es) Procedimiento para la preparacion de compuestos de cefem y cefam
ES485619A0 (es) Un procedimiento para la preparacion de derivados de diben- zopirano
SE8001747L (sv) Forfarande for framstellning av 1-fluorerade vitamin d-foreningar
ES490212A0 (es) Un procedimiento para la preparacion de fenetanolaminas
AR227379A1 (es) Procedimiento para la preparacion de 1-aril-2-imidazolil vinileteres
MX5898E (es) Procedimiento para la preparacion de 2-amino-4-pirimidonas
ES492954A0 (es) Un procedimiento para la preparacion de nuevos acidos feni- lalcanoicos
ES484930A0 (es) Un procedimiento para la preparacion de fenil-quinolicidinas
ES485554A0 (es) Un procedimiento para la preparacion de derivados de 5-fluoruracilo
ES484890A0 (es) Un procedimiento para la preparacion de derivados de ciclo- hexadieno
ES489048A0 (es) Un procedimiento para la preparacion de derivados de hidan- toina
ES484342A0 (es) Procedimiento para la preparacion de propenilensulfona
MX149694A (es) Procedimiento para la preparacion de trialcoxisilanos de fenoxialquilo
MX5996E (es) Procedimiento para la elaboracion de preparaciones solidas de alta estabilidad que contienen gefarnate
ES489648A0 (es) Un procedimiento para la preparacion de un derivado de cefa-losporina
ES490617A0 (es) Un procedimiento para la preparacion de derivados de oxadia-zolotriazona
ES483695A0 (es) Procedimiento para la preparacion de nuevos esteres de acidociclopropanocarboxilico sustituidos
ES490616A0 (es) Un procedimiento para la preparacion de derivados de oxadia-zolotriazona
AR228723A1 (es) Procedimiento para la preparacion de 2-cloro-4-etilamino-6-isopropilamino-s-triazina
ES486612A0 (es) Procedimiento para la preparacion de bencimidazol-carbamatos